Stocks and Investing Stocks and Investing
Tue, November 15, 2022
Mon, November 14, 2022

Robert Driscoll Maintained (ZNTL) at Buy with Decreased Target to $32 on, Nov 14th, 2022


Published on 2024-10-28 00:09:30 - WOPRAI, Robert Driscoll
  Print publication without navigation


Robert Driscoll of Wedbush, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Decreased Target from $51 to $32 on, Nov 14th, 2022.

Robert has made no other calls on ZNTL in the last 4 months.



There are 6 other peers that have a rating on ZNTL. Out of the 6 peers that are also analyzing ZNTL, 0 agree with Robert's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Robert


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $55 on, Friday, November 11th, 2022
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Decreased Target to $28 on, Friday, November 11th, 2022
  • Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $27 on, Thursday, November 10th, 2022
  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $50 on, Thursday, November 10th, 2022
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $58 on, Wednesday, November 9th, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Wednesday, August 10th, 2022
Contributing Sources